Correction: Improving the therapeutic efficacy of sorafenib for hepatocellular carcinoma by repurposing disulfiram

Frontiers in Oncology 2026 Open access

Read full text
Authors: Gong Zhang, Yufeng Wang, Bryan C. Fuchs, Wei Guo, David L. Drum, Derek J. Erstad, Baomin Shi, Albert B. DeLeo, Hui Zheng, Lei Cai, Liyuan Zhang, Kenneth K. Tanabe
+1 more Xinhui Wang
DOI: 10.3389/fonc.2026.1772315
Cited by: 0

Abstract

H, Cai L, Zhang L, Tanabe KK and Wang X (2022) Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram. Front. Oncol. 12:913736. doi: 10.3389/fonc.2022.913736In the published article, there was an error in Figure 2E as published. Some of the sphere images were unintentionally duplicated during the preparation process. The corrected Figure 2E and its caption appear below.

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Colorectal Cancer Treatments and Studies Liver physiology and pathology

Publication details

Journal / source
Frontiers in Oncology
Volume
16
Pages
1772315–1772315
Publication date
18 February 2026
Language
EN